title: Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density.
authors.affiliation: Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK. h.macdonald@abdn.ac.uk
authors.forename: H M
authors.initials: HM
authors.lastname: Macdonald
authors.forename: F E
authors.initials: FE
authors.lastname: McGuigan
authors.forename: W D
authors.initials: WD
authors.lastname: Fraser
authors.forename: S A
authors.initials: SA
authors.lastname: New
authors.forename: S H
authors.initials: SH
authors.lastname: Ralston
authors.forename: D M
authors.initials: DM
authors.lastname: Reid
mesh_terms: D015415:Biomarkers; D015519:Bone Density / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D006710:Homocysteine / Q000378:metabolism; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics* / Q000378:metabolism; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000235:genetics*; D012256:Riboflavin / Q000008:administration & dosage* / Q000494:pharmacology*
chemical_list: D015415:Biomarkers; D006710:Homocysteine; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D012256:Riboflavin